Cargando…

Engineering γδ T Cells: Recognizing and Activating on Their Own Way

Adoptive cell therapy (ACT) with engineered T cells has emerged as a promising strategy for the treatment of malignant tumors. Among them, there is great interest in engineered γδ T cells for ACT. With both adaptive and innate immune characteristics, γδ T cells can be activated by γδ TCRs to recogni...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Ruoyu, Zhang, Yixi, Xiao, Haowen, Zeng, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120431/
https://www.ncbi.nlm.nih.gov/pubmed/35603176
http://dx.doi.org/10.3389/fimmu.2022.889051